215 related articles for article (PubMed ID: 29916784)
1. Medical Maximizing-Minimizing Preferences Predict Responses to Information about Prostate-Specific Antigen Screening.
Scherer LD; Kullgren JT; Caverly T; Scherer AM; Shaffer VA; Fagerlin A; Zikmund-Fisher BJ
Med Decis Making; 2018 Aug; 38(6):708-718. PubMed ID: 29916784
[TBL] [Abstract][Full Text] [Related]
2. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
[TBL] [Abstract][Full Text] [Related]
3. Preferences for More or Less Health Care and Association With Health Literacy of Men Eligible for Prostate-Specific Antigen Screening in Australia.
Pickles K; Scherer LD; Cvejic E; Hersch J; Barratt A; McCaffery KJ
JAMA Netw Open; 2021 Oct; 4(10):e2128380. PubMed ID: 34636915
[TBL] [Abstract][Full Text] [Related]
4. A comparison of US and Australian men's values and preferences for PSA screening.
Howard K; Brenner AT; Lewis C; Sheridan S; Crutchfield T; Hawley S; Nielsen ME; Pignone MP
BMC Health Serv Res; 2013 Oct; 13():388. PubMed ID: 24093428
[TBL] [Abstract][Full Text] [Related]
5. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
[TBL] [Abstract][Full Text] [Related]
6. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
[TBL] [Abstract][Full Text] [Related]
7. Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review.
Vernooij RWM; Lytvyn L; Pardo-Hernandez H; Albarqouni L; Canelo-Aybar C; Campbell K; Agoritsas T
BMJ Open; 2018 Sep; 8(9):e025470. PubMed ID: 30185585
[TBL] [Abstract][Full Text] [Related]
8. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.
Flood AB; Wennberg JE; Nease RF; Fowler FJ; Ding J; Hynes LM
J Gen Intern Med; 1996 Jun; 11(6):342-9. PubMed ID: 8803740
[TBL] [Abstract][Full Text] [Related]
9. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
[TBL] [Abstract][Full Text] [Related]
10. Medical Maximizing-Minimizing Predicts Patient Preferences for High- and Low-Benefit Care.
Scherer LD; Shaffer VA; Caverly T; DeWitt J; Zikmund-Fisher BJ
Med Decis Making; 2020 Jan; 40(1):72-80. PubMed ID: 31975657
[No Abstract] [Full Text] [Related]
11. Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men: a contingent valuation survey.
Yasunaga H; Sugihara T; Imamura T
Urology; 2011 Jun; 77(6):1325-9. PubMed ID: 21507471
[TBL] [Abstract][Full Text] [Related]
12. Preparing African American Men to Make Informed Prostate Cancer Screening Decisions: Development and Pilot Testing of an Interactive Online Decision Aid.
Allen JD; Reich A; Cuevas AG; Ladin K
JMIR Mhealth Uhealth; 2020 May; 8(5):e15502. PubMed ID: 32369032
[TBL] [Abstract][Full Text] [Related]
13. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.
Gattellari M; Ward JE
J Med Screen; 2003; 10(1):27-39. PubMed ID: 12790313
[TBL] [Abstract][Full Text] [Related]
14. Online prostate cancer screening decision aid for at-risk men: a randomized trial.
Watts KJ; Meiser B; Wakefield CE; Barratt AL; Howard K; Cheah BC; Mann GJ; Lobb EA; Gaff CL; Patel MI
Health Psychol; 2014 Sep; 33(9):986-97. PubMed ID: 24274808
[TBL] [Abstract][Full Text] [Related]
15. Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
Avery KN; Metcalfe C; Vedhara K; Lane JA; Davis M; Neal DE; Hamdy FC; Donovan JL; Blazeby JM
Eur Urol; 2012 Oct; 62(4):649-55. PubMed ID: 22244151
[TBL] [Abstract][Full Text] [Related]
16. The influence of physician recommendation on prostate-specific antigen screening.
Pucheril D; Dalela D; Sammon J; Sood A; Sun M; Trinh QD; Menon M; Abdollah F
Urol Oncol; 2015 Oct; 33(10):424.e1-7. PubMed ID: 26206103
[TBL] [Abstract][Full Text] [Related]
17. Delivering the unexpected-Information needs for PSA screening from Men's perspective: A qualitative study.
Kuss K; Adarkwah CC; Becker M; Donner-Banzhoff N; Schloessler K
Health Expect; 2021 Aug; 24(4):1403-1412. PubMed ID: 34097797
[TBL] [Abstract][Full Text] [Related]
18. National evidence on the use of shared decision making in prostate-specific antigen screening.
Han PK; Kobrin S; Breen N; Joseph DA; Li J; Frosch DL; Klabunde CN
Ann Fam Med; 2013; 11(4):306-14. PubMed ID: 23835816
[TBL] [Abstract][Full Text] [Related]
19. Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.
Kirkegaard P; Edwards A; Nielsen TLO; Ørntoft TF; Sørensen KD; Borre M; Bro F
BMC Fam Pract; 2018 Feb; 19(1):32. PubMed ID: 29454309
[TBL] [Abstract][Full Text] [Related]
20. Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.
Fedewa SA; Gansler T; Smith R; Sauer AG; Wender R; Brawley OW; Jemal A
Ann Fam Med; 2018 Mar; 16(2):139-144. PubMed ID: 29531105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
